---

Herbal drugs: Boon for Peptic ulcer patients

Full Text PDF

---

Review Article

Author Details : Tapan Kumar Mahato*

Volume : 8, Issue : 1, Year : 2021

Article Page : 1-5

https://doi.org/10.18231/j.ijpca.2021.001

Suggest article by email

Get Permission

Abstract

Antibiotic, antiviral, antifungal and antiparasitic medicines are used to treat the diseases caused by pathogenic microorganisms. These microbes effects humans, animals and plants and produces diseases. As per the recent report of World Health Organization (WHO), the cases of Antimicrobial resistance (AMR) is continuously rising, which causes ineffective treatment and prevention of infections caused by bacteria, viruses, fungi and parasites. AMR occurs when these microbes gets resistance and the medications gets ineffective against these microbes, which makes treatment of common infections difficult and consequently increases the risk of severe illness, spread of disease and death. Because the medicines
becomes purposeless, infections continue to exist in the body and increases the likeliness of spread to others. WHO recommends reduced use of synthetic antibiotics and raised use of herbal antimicrobial drugs. These are the ways by which the AMR can be controlled or abolished. Herbal drugs can be used for this purpose because these are considered to be effective with no or less side effects. In the present article we discussed about peptic ulcer, causative agent of peptic ulcer and the medicinal plants which can be used to treat this disease. Twenty medicinal plants were listed which contains both antibacterial and antiulcer activity. Due to these properties of these medicinal plants, these can be used for the treatment of peptic
ulcer because of dual benefits firstly, antibacterial which kills or retards the growth of Helicobacter pylori and secondly, antiulcer which heals the ulcer.

Keywords: Antibacterial, Antimicrobial resistance, Antiulcer, Helicobacter pylori, Peptic ulcer.

How to cite : Mahato T K , Herbal drugs: Boon for Peptic ulcer patients. Int J Pharm Chem Anal 2021;8(1):1-5

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.